23andMe Gets FDA Green Light to Sell First Consumer DNA Test for Cancer Risk
The U.S. Food and Drug Administration has straighten out 23andMe to betray directly to customers a DNA test for gene mutations linked to boob cancer , progress to it the first consumer DNA examination troupe to succeed the federal agency ’s approval for a cancer risk screening . The new mental testing will analyse DNA for three specific BRCA1 and BRCA2 breast cancer gene chromosomal mutation . Though there are more than 1,000 known BRCA mutation , the 23andMe test will focalize on three mutations most common in citizenry of Ashkenazi Jewish descent ....